Sistemic announce a new article published on RegMedNet titled “In vitro assays for residual pluripotent stem cells in derived cell therapy products: what’s the current state of play?”

Release Date: March 30, 2020

Sistemic are delighted to announce a new article published on RegMedNet titled “In vitro assays for residual pluripotent stem cells in derived cell therapy products: what’s the current state of play?”.

In this article we discuss the current challenges and options for pluripotent stem cell therapies which require stringent quality control testing. 

The article can be found on RegMedNet’s website or by clicking the following link!

We hope everyone is keeping safe!

 

All the best,

The Team at Sistemic